Article Details

CGRP monoclonal antibodies improve benefit of onabotulinumtoxinA in patients with migraine

Retrieved on: 2021-06-04 19:52:30

Tags for this article:

Click the tags to see associated articles and topics

CGRP monoclonal antibodies improve benefit of onabotulinumtoxinA in patients with migraine. View article details on hiswai:

Excerpt

Patients with migraine who took calcitonin gene-related peptide-targeted monoclonal antibody therapy in combination with onabotulinumtoxinA had ...

Article found on: www.healio.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up